As per attached file

BLUE JET HEALTHCARE LIMITED ReGISTl:Reo & CORPORATe: 701 & 702, BHUMIRAJ COSTARICA. PLOT 1 & 2, SECTOR • 18, SANPAIOA , NAVI MUMBAI • 400705 BLUE JET T: 022· 41840550 / 40037600 F: +91 22 27814204 E: sa1es@blueje1heallhcare.com CIN NO. : l99999MH1968PLC01415'1 August 03, 2026 The Manager The Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejebhoy Towers Exchange Plaza, Plot No. C/1, G Block, Dalal Street Mumbai - 400 001 Bandra-Kurla Complex, Bandra (East) Scrip Code (BSE): 544009 Mumbai - 400051 Symbol: BLUEJET Sub.: Outcome of Board Meeting held today i.e, Monday, August 03, 2026. Dear Sir / Ma'am, In terms of Regulation 30 read with Schedule III and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that, the Board of Directors of the Company at their meeting held today viz. Monday, August 03, 2026, inter-alia, has approved the following: - a) Unaudited Standalone Financial Results of the Company for the first quarter ended June 30, 2026. A signed copy of the Unaudited Standalone Financial Results along with the Limited Review Report thereon is enclosed herewith as Annexure A b) Re-appointment of Mr. Akshay B Arora (DIN: 00105637) as the Whole Time Director and Executive Chairman for a further period of five (5) years, effective from April 13, 2027 to April 12, 2032, liable to retire by rotation, subject to the approval of the shareholders at the ensuing Annual General Meeting. The detailed disclosures as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as Annexure B; c) Re-appointment of Mr. Shiven Akshay Arora (DIN: 07351133) as the Managing Director of the Company for the further term of 5 years from April 13, 2027 to April 12, 2032, not liable to retire by rotation, subject to the approval of the shareholders at the ensuing Annual General Meeting. The detailed disclosures as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as Annexure C; Unl11 3/2, Milestone, Kalyan Murbad Road, Village Varap, P.O. Box No. 5. Shahad,421103, Tel.: 91 251 2280263 fax: +91 251 2260567 UnilU Plot No, 8-12, C-4, E-2, MIDC, lndusllial Area, Chemical Zone, Ambernath (W) 421501. Tel.: +91 8956363877/8956363878 Unltlll K-4/1, Add~lonal MIDC Road, Mahad Industrial Area, Mahad• 402309, Tel.: + 91 22 2207 5307 /6192 /1691 Fax: +91 22 2207 0294 Email : lnfo@bluejelheallhcare.com / Website : www.bluejethearthcare.com BLUE JET HEALTHCARE LIMITED ReGISTl:Reo & CORPORATe: 701 & 702, BHUMIRAJ COSTARICA. PLOT 1 & 2, SECTOR • 18, SANPAIOA , NAVI MUMBAI • 400705 BLUE JET T: 022· 41840550 / 40037600 F: +91 22 27814204 E: sa1es@blueje1heallhcare.com CIN NO. : l99999MH1968PLC01415'1 d) Re-appoint M/s KKC & Associates LLP, Chartered Accountants (ICAI Firm Registration No. 117366W/W-100018) as the Statutory Auditors of the Company for a second term of five consecutive years till the conclusion of the 63rd Annual General Meeting of the Company in terms of the aforesaid provisions, subject to the approval of the shareholders at the ensuing Annual General Meeting. The detailed disclosures as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as Annexure D; e) Record date September 14, 2026, for the purpose of determining entitlement to receive Dividend of Rs. 1.2/- (@ 60%) per Equity Share having face value of Rs. 2/- each fully paid-up for the financial year 2025- 26 as recommended by Board of the Directors at its meeting held on May 25, 2026. f) The 58th Annual General Meeting (“AGM”) of the Company will be held on September 21, 2026, at 11:00 A.M. IST through Video Conferencing ('VC') or Other Audio-Visual Means (OAVM'). The Notice of the AGM and the Annual Report will be released in due course. The meeting commenced at 12:10 P.M. and concluded at 12:27 P.M. Kindly take the same on your record. Thanking you, Yours faithfully, For Blue Jet Healthcare Limited Sweta Poddar Company Secretary & Compliance Officer Mem. No. F12287 Unl11 3/2, Milestone, Kalyan Murbad Road, Village Varap, P.O. Box No. 5. Shahad,421103, Tel.: 91 251 2280263 fax: +91 251 2260567 UnilU Plot No, 8-12, C-4, E-2, MIDC, lndusllial Area, Chemical Zone, Ambernath (W) 421501. Tel.: +91 8956363877/8956363878 Unltlll K-4/1, Add~lonal MIDC Road, Mahad Industrial Area, Mahad• 402309, Tel.: + 91 22 2207 5307 /6192 /1691 Fax: +91 22 2207 0294 Email : lnfo@bluejelheallhcare.com / Website : www.bluejethearthcare.com kkc & associates lip Chartered Accountants (formerly Khimji Kunverji & Co LLP) Independent Auditor's Review Report on unaudited financial results for the quarter ended 30 June 2026 of Blue Jet Healthcare Limited under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The Board of Directors of Blue Jet Healthcare Limited Introduction 1. We have reviewed the accompanying statement of unaudited financial results of Blue Jet Healthcare Limited ('the Company') for the quarter ended 30 June 2026 ('the Statement'), being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India {Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations'). We have initialled the Statement for identification purpose only. 2. This Statement, which is the responsibility of the Company's Management and approved by the Board of Directors of the Company, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard ('Ind AS') 34 'Interim Financial Reporting' specified in section 133 of the Companies Act, 2013 ('the Act'), read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. Scope of Review 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements ('SRE') 2410 -'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India ('the ICAI'). This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company's personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Conclusion 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS, specified under Section 133 of the Act as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Sunshine Tower, Level 19, Senapati Ba pat Marg, Elphinstone Road, Mumbai 400013, India T: +9122 6143 7333 E: info@kkcllp.in W: www.kkcllp.in LLPIN: AAP-2267 Suite 52, Bombay Mutual Building, Sir Phirozshah Mehta Road, Fort, Mumbai 400001, India kkc & associates lip Chartered Accountants (formerly Khimji Kunverji & Co LLP) Other Matter 5. Attention is drawn to the fact that the figures for the quarter ended 31 March 2026 as report [Showing first 8,000 characters — download PDF for full document]